Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.

Saved in:
Bibliographic Details
Title: Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.
Authors: Chatterji S; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Aberdeen Cancer Centre, University of Aberdeen, Aberdeen, UK., Niehues JM; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany., van Treeck M; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany., Loeffler CML; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany.; Department of Medicine I, University Hospital and Faculty of Medicine, Technical University of Dresden, Dresden, Germany., Saldanha OL; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany., Veldhuizen GP; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany., Cifci D; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany., Carrero ZI; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany., Abu-Eid R; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Aberdeen Cancer Centre, University of Aberdeen, Aberdeen, UK.; Institute of Dentistry, University of Aberdeen, Aberdeen, UK., Speirs V; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK. valerie.speirs@abdn.ac.uk.; Aberdeen Cancer Centre, University of Aberdeen, Aberdeen, UK. valerie.speirs@abdn.ac.uk., Kather JN; Else Kröner Fresenius Centre for Digital Health, Carl Gustav Carus Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Department of Medicine III, University Hospital RWTH (Rheinisch-Westfälische Technische Hochschule) Aachen, Aachen, Germany.; Department of Medicine I, University Hospital and Faculty of Medicine, Technical University of Dresden, Dresden, Germany.; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Source: NPJ breast cancer [NPJ Breast Cancer] 2023 Nov 08; Vol. 9 (1), pp. 91. Date of Electronic Publication: 2023 Nov 08.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2374-4677
DOI:10.1038/s41523-023-00599-y